Friday, June 19, 2026
🇺🇸 FDA

pharma · Metastatic Colorectal Cancer · Duchenne Muscular Dystrophy · SMMT

Summit Therapeutics

Summit Therapeutics clinical programs — 41 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US HQ
2003 Founded
367 Employees
Public company Type
SMMT · NYSE Ticker
Company details
Status
Public
HQ
601 Brickell Key Dr, Suite 1000, Miami, Florida 33131, US
Founded
2003
Employees
367
Programs
41
Drugs
32
Patents
20
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Summit Therapeutics projects

41 ClinicalTrials.gov programs sponsored by Summit Therapeutics.

Summit Therapeutics has 41 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

41 programs

Clinical programs

  1. AK112 Injection

    Summit Therapeutics

    Non-Squamous Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  2. Acupuncture

    Summit Therapeutics

    Fatigue

    phase 3 other active

    1 trial

  3. Drug: Ivonescimab Injection

    Summit Therapeutics

    Metastatic Colorectal Cancer (CRC)

    phase 3 small molecule active

    1 trial

  4. Ivonescimab 10 mg/kg

    Summit Therapeutics

    Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

    phase 3 small molecule active

    1 trial

  5. Ivonescimab Injection

    Summit Therapeutics

    Non-Small Cell Lung Cancer

    phase 3 mab active

    2 trials

  6. Ridinilazole

    Summit Therapeutics

    Clostridioides Difficile Infection

    phase 3 small molecule completed

    2 trials

  7. SMT112-3003

    Summit Therapeutics

    Metastatic Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  8. SMT112-3003

    Summit Therapeutics

    Metastatic Squamous Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  9. SMT112-3005

    Summit Therapeutics

    Metastatic colorectal cancer

    phase 3 small molecule active

    1 trial

  10. AK112

    Summit Therapeutics

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  11. Ezutromid

    Summit Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule terminated

    1 trial

  12. Hyperbaric Oxygen Therapy

    Summit Therapeutics

    TBI Traumatic Brain Injury

    phase 2 small molecule active

    1 trial

  13. Ivonescimab

    Summit Therapeutics

    Pleural Mesotheliomas

    phase 2 small molecule active

    1 trial

  14. Ivonescimab

    Summit Therapeutics

    Salivary Gland Cancer

    phase 2 small molecule active

    1 trial

  15. Ivonescimab

    Summit Therapeutics

    Advanced Head and Neck Squamous Cell Carcinoma

    phase 2 mab active

    1 trial

  16. Ivonescimab

    Summit Therapeutics

    Biliary Tract Cancer

    phase 2 small molecule active

    1 trial

  17. Ivonescimab

    Summit Therapeutics

    Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  18. Ivonescimab

    Summit Therapeutics

    Endometrial Cancer

    phase 2 small molecule active

    1 trial

  19. Ivonescimab

    Summit Therapeutics

    Glioblastoma

    phase 2 small molecule active

    1 trial

  20. Ivonescimab

    Summit Therapeutics

    Ivonescimab

    phase 2 small molecule active

    1 trial

  21. Ivonescimab

    Summit Therapeutics

    Leiomyosarcoma

    phase 2 small molecule active

    1 trial

  22. Ivonescimab

    Summit Therapeutics

    Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  23. Ivonescimab

    Summit Therapeutics

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    2 trials

  24. Ivonescimab

    Summit Therapeutics

    Metastatic Esophageal Adenocarcinoma

    phase 2 small molecule active

    1 trial

  25. Ivonescimab

    Summit Therapeutics

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    3 trials

  26. Ivonescimab

    Summit Therapeutics

    Stomach Cancer Stage IV

    phase 2 small molecule active

    1 trial

  27. Ivonescimab

    Summit Therapeutics

    Thymus Carcinoma

    phase 2 mab active

    1 trial

  28. Ivonescimab

    Summit Therapeutics

    TNBC

    phase 2 small molecule active

    1 trial

  29. Ivonescimab 10 mg/kg

    Summit Therapeutics

    Extensive Stage Lung Small Cell Cancer

    phase 2 small molecule active

    1 trial

  30. Nebivolol Ophthalmic Suspension 1 Percent

    Summit Therapeutics

    Open-Angle Glaucoma

    phase 2 small molecule completed

    1 trial

  31. Ridinilazole

    Summit Therapeutics

    Clostridium Difficile Infection

    phase 2 small molecule completed

    1 trial

  32. SMT19969

    Summit Therapeutics

    Clostridium Difficile Infection

    phase 2 small molecule completed

    1 trial

  33. Replens and coconut oil

    Summit Therapeutics

    Genitourinary Abnormality

    phase 1 other terminated

    1 trial

  34. SMT C1100

    Summit Therapeutics

    Duchenne Muscular Dystrophy

    phase 1 small molecule completed

    1 trial

  35. SMT C1100

    Summit Therapeutics

    Muscular Dystrophy, Duchenne

    phase 1 small molecule completed

    1 trial

  36. ketamine

    Summit Therapeutics

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

  37. Control: Femoral perineural local anesthetic infusion

    Summit Therapeutics

    Postoperative Pain Following Knee Arthroplasty

    approved small molecule completed

    1 trial

  38. VENDY

    Summit Therapeutics

    Harm Reduction

    approved other active

    1 trial

  39. Bottle pack

    Summit Therapeutics

    Pregnancy

    other active

    1 trial

  40. Fish Oil

    Summit Therapeutics

    Heart Disease

    other completed

    1 trial

  41. Infasurf

    Summit Therapeutics

    Respiratory Distress Syndrome

    small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Summit Therapeutics have?

41 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.